# Improving Outcomes of Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma: New Data and Ongoing Trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/improving-outcomes-of-tyrosine-kinase-inhibitors-in-hepatocellular-carcinoma-new/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lisha Mou,Xiaohe Tian,Bo Zhou,Yongqiang Zhan,Jiao Chen,Ying Lu,Jing Deng,Ying Deng,Zijing Wu,Qi Li,Yi’an Song,Hongyuan Zhang,Jinjun Chen,Kuifeng Tian,Yong Ni,Zuhui Pu |
| Citations | 74 |
| DOI | 10.3389/fonc.2021.752725 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fonc.2021.752725/pdf |
| OpenAlex ID | https://openalex.org/W3205776856 |
| PMID | 34707994 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Ying Lu](https://scholariq.org/researchers/ying-lu/)

## Paper journal

- [Frontiers in Oncology](https://scholariq.org/journals/frontiers-in-oncology/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.